Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. C. De Salvo, J. A. Gonzalez, D. R. Rey, A. M. Miranda (Buenos Aires, Argentina). Interstitial lung diseases, mortality and associated risk factors. Eur Respir J 2004; 24: Suppl. 48, 4074

Member's Comments

No comment yet.

Related content which might interest you: Risk factors associated with the development of interstitial lung abnormalities Source: Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020 Year: 2021 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Incidence and risk factors for structural lung disease following SARS-CoV-2 infection Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Associations between comorbidities and survival in patients with interstitial lung diseases Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Interstitial lung abnormalities in smokers are associated with increased mortality Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011 Interstital lung disease rates and risk factors in a UK lung cancer screening trial Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Intolarence of pirfenidone and its associated factors in the real world Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Interstitial lung diseases associated with lung cancer Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Risk factors for lung cancer worldwide Source: Eur Respir J 2016; 48: 889-902 Year: 2016 Combination of risk factors of bronchopulmonary and cardiovascular diseases in people of young age Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 Effect of autoimmune diseases on risk and survival in histology-specific lung cancer Source: Eur Respir J 2012; 40: 1489-1495 Year: 2012 The associations of interstitial lung abnormalities with cancer diagnoses and mortality Source: Eur Respir J, 56 (6) 1902154; 10.1183/13993003.02154-2019 Year: 2020 Incidence, risk factors and outcomes of nonresolving pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010